FindTrial
Sign In

Transdermal Nicotine

DRUG9 trials

Sponsors

US Department of Veterans Affairs, Assistance Publique - Hôpitaux de Paris, Butler Hospital, University of Memphis, University of Pennsylvania

Conditions

AggressionAutism Spectrum DisorderBreast CancerChemo BrainChemo FogChemobrainChemotherapy-related Cognitive ImpairmentCigarette Smoking

Phase 1

Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism
CompletedNCT02552147
Yale UniversityAggression, Autism Spectrum Disorder, Irritability
Start: 2015-09-30End: 2017-11-17Updated: 2022-05-06

Phase 2

Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation
CompletedNCT00018148
US Department of Veterans AffairsSmoking
Start: 1998-04-30End: 2003-01-31Updated: 2010-09-15
Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease
CompletedNCT00873392
Assistance Publique - Hôpitaux de ParisIdiopathic Parkinson's Disease
Start: 2009-02-28End: 2013-05-31Updated: 2013-12-31
Nicotine Patch Trial in Syrian Primary Care Settings
CompletedNCT01085032
University of MemphisSmoking Cessation
Start: 2006-08-31End: 2009-07-31Updated: 2010-03-11
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
CompletedNCT01484717
UConn HealthCigarette Smoking
Start: 2012-01-31End: 2014-12-31Updated: 2017-02-20
Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study
CompletedNCT02312934
Vanderbilt University Medical CenterBreast Cancer, Chemobrain, Chemo Brain +2
Start: 2015-08-31End: 2018-05-31Updated: 2020-01-21

Phase 3

Pharmacogenetics of Nicotine Addiction Treatment
CompletedNCT01314001
University of PennsylvaniaNicotine Addiction
Start: 2010-12-31End: 2014-09-30Updated: 2016-03-03

Unknown Phase

Naltrexone and Patch for Smokers
CompletedNCT00018213
US Department of Veterans AffairsSmoking
Start: 1998-04-30End: 2001-03-31Updated: 2009-01-21
Coping Skills Treatment for Smoking Cessation
CompletedNCT01061528
Butler HospitalNicotine Dependence
Start: 2009-09-30End: 2013-10-31Updated: 2018-10-16

Related Papers

Daily Cigarette Abstinence and Smoking Rate With Varenicline: Relationships With Treatment, Craving, and Affect During the First Week of the Quit Attempt.
2025-11-01
Sex dependent genetic architecture of biochemically verified tobacco use.
2025-03-26
Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome‐Wide Investigation of Abnormal Dreams on Varenicline
Clinical Pharmacology & Therapeutics2024-02-191 citations
Influence of <i>CYP2A6</i> Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success
Nicotine & Tobacco Research2023-02-158 citations
Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving
Nicotine & Tobacco Research2022-05-267 citations
Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans
Scientific Reports2021-10-0117 citations
A Genome-Wide Association Study of Nausea Incidence in Varenicline-Treated Cigarette Smokers
Nicotine & Tobacco Research2021-03-115 citations
Impact of early nausea on varenicline adherence and smoking cessation
Addiction2019-09-1027 citations
Differences in the rate of nicotine metabolism among smokers with and without HIV.
2019-05-0146 citations
Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity
Addiction Biology2019-02-2731 citations
Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
2018-06-2611 citations
Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
2017-11-0244 citations
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.
2015-06-1121 citations
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers
Nicotine & Tobacco Research2015-03-0117 citations
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
2015-01-12245 citations
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
2014-07-1094 citations